Add files using upload-large-folder tool
Browse files- .DS_Store +0 -0
- human_readable/.DS_Store +0 -0
- human_readable/pdf/.DS_Store +0 -0
- human_readable/pdf/chlamydia_newzealand.pdf +0 -0
- human_readable/txt/.DS_Store +0 -0
- human_readable/txt/acuteflaccidparalysis_kenya +3 -0
- human_readable/txt/arbovirosis_paraguay +15 -0
- human_readable/txt/avianinfluenzainhumans_australia +9 -0
- human_readable/txt/babesiosis_canada +21 -0
- human_readable/txt/chlamydia_newzealand +6 -0
- human_readable/txt/cholera_colombia +9 -0
- human_readable/txt/cholera_ghana +5 -0
- human_readable/txt/covid19_egypt +37 -0
- human_readable/txt/covid19_philippines +20 -0
- human_readable/txt/dengue_usa +115 -0
- human_readable/txt/denguefever_malaysia +4 -0
- human_readable/txt/diabetesmellitusnoinsulinodepedientetypeII_mexico +3 -0
- human_readable/txt/diarrhea_pacificislands +2 -0
- human_readable/txt/ebola_spain +9 -0
- human_readable/txt/ebolaandmarburgvirus_who +9 -0
- human_readable/txt/equineencephalitis_guatemala +9 -0
- human_readable/txt/extremetemperaturescold_argentina +9 -0
- human_readable/txt/extremetemperaturesheat_argentina +10 -0
- human_readable/txt/humannipahvirus_bangladesh +19 -0
- human_readable/txt/influenzalikeillness_africa_africacdc +7 -0
- human_readable/txt/influenzalikeillness_brazil +9 -0
- human_readable/txt/intussusception_vietnam +12 -0
- human_readable/txt/legionnairesdisease_uk +5 -0
- human_readable/txt/leptospirosis_germany +12 -0
- human_readable/txt/lujo_southafrica +22 -0
- human_readable/txt/malaria_nigeria +3 -0
- human_readable/txt/measles_china +2 -0
- human_readable/txt/measles_ethiopia +6 -0
- human_readable/txt/measles_india +5 -0
- human_readable/txt/meningococcalmeningitis_mozambique +6 -0
- human_readable/txt/middleeastrespiratorysyndrome_saudiarabia +22 -0
- human_readable/txt/mpox_france +6 -0
- human_readable/txt/mumps_ireland +4 -0
- human_readable/txt/plague_peru +7 -0
- human_readable/txt/smallpox_costarica +18 -0
- human_readable/txt/syphiliscongenitalandneonatal_greece +22 -0
- human_readable/txt/tuberculosis_europe_ecdc +8 -0
- human_readable/txt/viralhepatitis_turkey +8 -0
- human_readable/txt/wheezeorapneaorcyanosis_pakistan +1 -0
- human_readable/txt/zika_paho +8 -0
- machine_readable/.DS_Store +0 -0
- machine_readable/json/chlamydia_newzealand.json +59 -0
- machine_readable/json/ebolaandmarburgvirus_who.json +133 -0
- machine_readable/json/lujo_southafrica.json +124 -0
- machine_readable/json/measles_china.json +79 -0
.DS_Store
ADDED
|
Binary file (6.15 kB). View file
|
|
|
human_readable/.DS_Store
ADDED
|
Binary file (10.2 kB). View file
|
|
|
human_readable/pdf/.DS_Store
ADDED
|
Binary file (6.15 kB). View file
|
|
|
human_readable/pdf/chlamydia_newzealand.pdf
ADDED
|
Binary file (88.5 kB). View file
|
|
|
human_readable/txt/.DS_Store
ADDED
|
Binary file (6.15 kB). View file
|
|
|
human_readable/txt/acuteflaccidparalysis_kenya
ADDED
|
@@ -0,0 +1,3 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Suspected case: Any case with weakness or floppiness of the limbs of sudden onset not due to trauma in a child less than
|
| 2 |
+
(Poliomyelitis)
|
| 3 |
+
15 years of age, or any person of any age in whom a clinician suspects polio
|
human_readable/txt/arbovirosis_paraguay
ADDED
|
@@ -0,0 +1,15 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Arbovirosis en
|
| 2 |
+
IV - Vectoriales: arbovirosis y parasitosis
|
| 3 |
+
Fiebre
|
| 4 |
+
indiferenciada
|
| 5 |
+
por picadura
|
| 6 |
+
de mosquito.
|
| 7 |
+
Síndrome febril
|
| 8 |
+
agudo sin
|
| 9 |
+
causa aparente
|
| 10 |
+
A92.9 Universal
|
| 11 |
+
Caso
|
| 12 |
+
sospechoso de
|
| 13 |
+
arbovirosis
|
| 14 |
+
Clínica INDIVIDUAL
|
| 15 |
+
INMEDIATO
|
human_readable/txt/avianinfluenzainhumans_australia
ADDED
|
@@ -0,0 +1,9 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Clinical evidence
|
| 2 |
+
An acute illness characterised by:
|
| 3 |
+
1. Fever (>38°C) or history of fever AND one or more of; cough OR rhinorrhoea OR
|
| 4 |
+
myalgia OR headache OR dyspnoea OR diarrhoea;
|
| 5 |
+
OR
|
| 6 |
+
2. Conjunctivitis
|
| 7 |
+
OR
|
| 8 |
+
3. Infiltrates or evidence of an acute pneumonia on a chest radiograph plus evidence
|
| 9 |
+
of acute respiratory insufficiency (hypoxaemia, severe tachypnoea).
|
human_readable/txt/babesiosis_canada
ADDED
|
@@ -0,0 +1,21 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Clinical evidence
|
| 2 |
+
Clinical description:
|
| 3 |
+
Babesiosis infections range in severity from asymptomatic to severe
|
| 4 |
+
(occasionally fatal) depending on host and parasite factors. Most
|
| 5 |
+
symptomatic infections caused by B. microti are mild and self-limiting,
|
| 6 |
+
developing 1 to 4 weeks after the tick bite and 1 to 9 weeks after
|
| 7 |
+
contamination of blood products. 1
|
| 8 |
+
The salient features are fever and
|
| 9 |
+
non-specific flu-like illness (malaise, fatigue, chills, sweats, and
|
| 10 |
+
headache).
|
| 11 |
+
Laboratory findings can include hemolytic anemia, thrombocytopenia.
|
| 12 |
+
Patients who are asplenic, immunocompromised, elderly, or co-infected
|
| 13 |
+
with other pathogens are at risk for severe disease. 1 2 3
|
| 14 |
+
, ,
|
| 15 |
+
Severe babesiosis is associated with a parasitemia of 10% or greater;
|
| 16 |
+
hemolytic anemia; pulmonary, renal, and hepatic complications; and
|
| 17 |
+
death.
|
| 18 |
+
4
|
| 19 |
+
Clinical criteria:
|
| 20 |
+
Clinical criteria include fever and at least one of fatigue, chills, sweats,
|
| 21 |
+
headache, anorexia, hemolytic anemia, or thrombocytopenia.
|
human_readable/txt/chlamydia_newzealand
ADDED
|
@@ -0,0 +1,6 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Chlamydia Confirmed Probable Laboratory detection of Chlamydia trachomatis in a clinical specimen.
|
| 2 |
+
Cases should be classified as:
|
| 3 |
+
1. uncomplicated infection of the lower anogenital* tract
|
| 4 |
+
* Includes urogenital and anorectal infection.
|
| 5 |
+
2. 3. PID (pelvic inflammatory disease) or epididymitis
|
| 6 |
+
infection of another site (eg, eye or pharynx)
|
human_readable/txt/cholera_colombia
ADDED
|
@@ -0,0 +1,9 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Es el caso sospechoso que cumple con cualquiera de los siguientes criterios.
|
| 2 |
+
Confirmación por laboratorio con cultivo de heces positivo para Vibrio cholerae O1 u O139 toxigénico.
|
| 3 |
+
Confirmación por nexo epidemiológico:
|
| 4 |
+
• Individuo que cumple con la definición de caso sospechoso, y tiene historia de contacto con un
|
| 5 |
+
enfermo de cólera confirmado por laboratorio dentro de un período de cinco días
|
| 6 |
+
• o antecedente de circulación activa del V. cholerae serotipo O1 u O139 toxigénico en el área de
|
| 7 |
+
trabajo o residencia del caso.
|
| 8 |
+
Se considera área de circulación activa aquella en donde el V. cholerae O1 u O139 toxigénico ha sido
|
| 9 |
+
aislado de muestras biológicas o ambientales (agua, alimentos o restos de alimentos).
|
human_readable/txt/cholera_ghana
ADDED
|
@@ -0,0 +1,5 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Suspected case:
|
| 2 |
+
(rice water stool).
|
| 3 |
+
In a patient age 5 years or more, severe dehydration or death from acute watery diarrhoea
|
| 4 |
+
If there is a cholera epidemic, a suspected case is a person age 5 years or more with acute
|
| 5 |
+
watery diarrhoea, with or without vomiting.
|
human_readable/txt/covid19_egypt
ADDED
|
@@ -0,0 +1,37 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
A
|
| 2 |
+
Any one of the epidemiological
|
| 3 |
+
history with any of the clinical
|
| 4 |
+
features.
|
| 5 |
+
epidemiological history:
|
| 6 |
+
1. History of travel to or
|
| 7 |
+
residence in communities
|
| 8 |
+
where cases reported within
|
| 9 |
+
the last 14 days.
|
| 10 |
+
2. In contact with viral RNA
|
| 11 |
+
positive people
|
| 12 |
+
within the last 14 days.
|
| 13 |
+
3. In contact with a patient who
|
| 14 |
+
has fever or respiratory
|
| 15 |
+
symptoms or from a
|
| 16 |
+
community
|
| 17 |
+
with confirmed cases reported
|
| 18 |
+
within the last 14 days.
|
| 19 |
+
B
|
| 20 |
+
OR OR
|
| 21 |
+
Asessing the presence of at
|
| 22 |
+
least two of the following
|
| 23 |
+
clinical features:
|
| 24 |
+
1.Fever and/or respiratory
|
| 25 |
+
symptoms.
|
| 26 |
+
2.Imaging characteristics.
|
| 27 |
+
CT scan is preferred, if not
|
| 28 |
+
appicable do CXR
|
| 29 |
+
3.Differential CBC findings:
|
| 30 |
+
white blood cells is normal
|
| 31 |
+
or decreased, with decreased
|
| 32 |
+
lymphocytic count.
|
| 33 |
+
C
|
| 34 |
+
Severe Acute Respiratory
|
| 35 |
+
Infection
|
| 36 |
+
(SARI) with no other
|
| 37 |
+
obvious cause.
|
human_readable/txt/covid19_philippines
ADDED
|
@@ -0,0 +1,20 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
A. Suspect Case
|
| 2 |
+
1. A person who meets the clinical AND epidemiologic criteria:
|
| 3 |
+
a. Clinical criteria
|
| 4 |
+
i. Acute onset of fever AND cough OR
|
| 5 |
+
ii. Acute onset of any of the three or more of the following signs or symptoms:
|
| 6 |
+
fever, cough, general weakness, fatigue, headache, myalgia, sore throat,
|
| 7 |
+
coryza, dyspnea, anorexia/nausea/vomiting/diarrhea, altered mental
|
| 8 |
+
status
|
| 9 |
+
b. Epidemiologic criteria
|
| 10 |
+
i. Residing or working in an area with high risk of transmission of the virus:
|
| 11 |
+
for example, closed residential settings and humanitarian settings such as
|
| 12 |
+
camp and camp-like settings for displaced persons, any time within the 14
|
| 13 |
+
days prior to symptoms onset; OR
|
| 14 |
+
ii. Residing in or travel to an area with community transmission anytime within
|
| 15 |
+
the 14 days prior to symptom onset OR
|
| 16 |
+
iii. Working in health settings including within health facilities and within
|
| 17 |
+
households, anytime within the 14 days prior to symptoms onset
|
| 18 |
+
c. Patient with severe acute respiratory illness (SARI: acute respiratory infection
|
| 19 |
+
with history of fever or measured fever > 38 C, and cough with onset within the
|
| 20 |
+
last 10 days and who require hospitalization)
|
human_readable/txt/dengue_usa
ADDED
|
@@ -0,0 +1,115 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
|
| 2 |
+
Definition Purpose: Created by the CDC National Syndromic Surveillance Program (NSSP) for use with ED
|
| 3 |
+
data as part of the rapid reportables project, which seeks to create queries for all National Notifiable
|
| 4 |
+
Diseases defined by the National Notifiable Diseases Surveillance System (NNDSS). This query is intended
|
| 5 |
+
to be a version 1 and may be further improved upon by the NSSP community of practice in the future. This
|
| 6 |
+
query is intended to be narrow and capture visits with specific terms to support greater monitoring and
|
| 7 |
+
actionable public health data. More complex and/or broader que ries may exist that more broadly capture
|
| 8 |
+
symptoms or travel-based terms.
|
| 9 |
+
|
| 10 |
+
New or Revised Definition: New Definition
|
| 11 |
+
|
| 12 |
+
Date Added to ESSENCE: July 2024
|
| 13 |
+
|
| 14 |
+
Definition Description: Designed to capture emergency department visits associated with dengue infection.
|
| 15 |
+
|
| 16 |
+
Use-Cases for Definition:
|
| 17 |
+
☒ Case-finding
|
| 18 |
+
☒ Trend monitoring
|
| 19 |
+
☒ Early outbreak detection
|
| 20 |
+
|
| 21 |
+
Justification: No query definition exists for dengue virus infections. CDC wants to use syndromic data to
|
| 22 |
+
monitor trends.
|
| 23 |
+
|
| 24 |
+
Data Source During Development : Emergency Department Visits. Chief Complaint Query Validation
|
| 25 |
+
dataset (CCQV) in ESSENCE.
|
| 26 |
+
|
| 27 |
+
Development Methods:
|
| 28 |
+
1. The CDC team used the NNDSS case definition of dengue virus Infections to identify diagnostic
|
| 29 |
+
codes (International Classification of Diseases, 9th & 10th Revision s (ICD-9-CM, ICD -10-CM),
|
| 30 |
+
SNOMED Clinical Terms (CT)) and chief complaint free text for syndrome development.
|
| 31 |
+
2. The codes and free text were then categorized as inclusion or exclusion terms. These terms were
|
| 32 |
+
formatted for querying in ESSENCE.
|
| 33 |
+
3. Text analysis was conducted on the initial query to find additional inclusion or exclusion terms.
|
| 34 |
+
4. The query was cross-checked internally by NSSP and by CDC subject matter experts as needed.
|
| 35 |
+
|
| 36 |
+
Validation Methods: This definition is part of the collection of definitions created by CDC NSSP for the rapid
|
| 37 |
+
reportables project. The rapid reportables project is led by the CDC NSSP team to create definitions for all
|
| 38 |
+
nationally reportable diseases. These definitions focus on chief complaint text and diagnostic codes of the
|
| 39 |
+
Dengue v1
|
| 40 |
+
Definition Factsheet & Technical Brief
|
| 41 |
+
|
| 42 |
+
Authors: Andzelika Rzucidlo, MPH 1,2, Dylan Johns, MS 1,3, Anna Frick, MPH 4, Sara Chronister, MPH 5,
|
| 43 |
+
David Atrubin6, Katharina L. van Santen, MSPH1,3
|
| 44 |
+
|
| 45 |
+
1 CDC Office of Public Health Data, Surveillance, and Technology (OPHDST), Immediate Office of the Director
|
| 46 |
+
(IOD), Integrated Monitoring Branch
|
| 47 |
+
2 InductiveHealth
|
| 48 |
+
3 ICF
|
| 49 |
+
4 Alaska Division of Public Health
|
| 50 |
+
5 Washington State Department of Health
|
| 51 |
+
6 Florida Department of Health
|
| 52 |
+
|
| 53 |
+
Point of contact:
|
| 54 |
+
nssp@cdc.gov
|
| 55 |
+
disease or its causative agents with no mention of symptoms. Select members of the Community of Practice
|
| 56 |
+
were then asked to review line -level results for their jurisdictions and provide feedback to ensure the
|
| 57 |
+
intended results of the definitions were met.
|
| 58 |
+
|
| 59 |
+
Definition Fields and Structure:
|
| 60 |
+
The Chief Complaint Discharge Diagnosis (CCDD) parsed field is used to query both the discharge
|
| 61 |
+
diagnosis codes and chief complaint free text.
|
| 62 |
+
• Inclusion based on dengue virus chief complaint free-text terms:
|
| 63 |
+
o The visit is included if it contains:
|
| 64 |
+
1. Chief complaints related to the pathogen name – (“dengue”) OR
|
| 65 |
+
• Inclusion based on ICD-10 discharge diagnosis codes related to dengue virus:
|
| 66 |
+
o The visit is included if it contains:
|
| 67 |
+
1. A discharge diagnosis code of Dengue fever [classical dengue] (A90) OR
|
| 68 |
+
2. A discharge diagnosis code of Dengue hemorrhagic fever (A91) OR
|
| 69 |
+
|
| 70 |
+
• Inclusion based on ICD-9 discharge diagnosis codes related to dengue virus:
|
| 71 |
+
o The visit is included if it contains:
|
| 72 |
+
1. A discharge diagnosis code of Dengue (061) OR
|
| 73 |
+
• Inclusion based on SNOMED discharge diagnosis code s related to active infection with dengue
|
| 74 |
+
virus:
|
| 75 |
+
o The visit is included if it contains:
|
| 76 |
+
1. A discharge diagnosis code of Dengue (38362002) OR
|
| 77 |
+
2. A discharge diagnosis code of severe Dengue (20927009) OR
|
| 78 |
+
3. A discharge diagnosis code of Dengue shock syndrome (409671005) OR
|
| 79 |
+
4. A discharge diagnosis code of myelitis caused by Dengue virus (866057003) OR
|
| 80 |
+
5. A discharge diagnosis code of Encephalitis caused by Dengue virus (1163101003)
|
| 81 |
+
• No exclusion terms or codes are used in this query.
|
| 82 |
+
|
| 83 |
+
Detailed Definition Components
|
| 84 |
+
Table 1. Inclusion and exclusion terms.
|
| 85 |
+
Variable
|
| 86 |
+
Type
|
| 87 |
+
Terms Description
|
| 88 |
+
Inclusions
|
| 89 |
+
Discharge
|
| 90 |
+
Diagnosis:
|
| 91 |
+
ICD-10-
|
| 92 |
+
CM
|
| 93 |
+
A90 Dengue fever [classical dengue]
|
| 94 |
+
A91 Dengue hemorrhagic fever
|
| 95 |
+
Discharge
|
| 96 |
+
Diagnosis:
|
| 97 |
+
ICD-9-CM
|
| 98 |
+
061 Dengue
|
| 99 |
+
Discharge
|
| 100 |
+
Diagnosis:
|
| 101 |
+
SNOMED
|
| 102 |
+
concepts
|
| 103 |
+
38362002 Dengue
|
| 104 |
+
20927009 Severe dengue
|
| 105 |
+
409671005 Dengue shock syndrome
|
| 106 |
+
866057003 Myelitis caused by Dengue virus
|
| 107 |
+
1163101003 Encephalitis caused by Dengue virus
|
| 108 |
+
Chief
|
| 109 |
+
Complaint
|
| 110 |
+
Terms
|
| 111 |
+
Dengue
|
| 112 |
+
|
| 113 |
+
Table 2. ESSENCE syntax
|
| 114 |
+
^dengue^,or,^;A9[01]^,or,^;061;^,or,^;38362002;^,or,^;20927009;^,or,^;409671005;^,or,^;866057003;^,or
|
| 115 |
+
,^;1163101003;^
|
human_readable/txt/denguefever_malaysia
ADDED
|
@@ -0,0 +1,4 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Dengue Fever
|
| 2 |
+
Acute onset of high grade fever of usually 2-5 days or more associated with two or more
|
| 3 |
+
of the following: headache, retro-orbital pain, myalgia, arthralgia, rash and mild
|
| 4 |
+
haemorrhagic manifestation (epistaxis, gums bleeding and petechiae).
|
human_readable/txt/diabetesmellitusnoinsulinodepedientetypeII_mexico
ADDED
|
@@ -0,0 +1,3 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Caso sospechoso: Toda persona que reúna los siguientes criterios:
|
| 2 |
+
poliuria, polidipsia y polifagia, más una glucemia plasmática casual mayor
|
| 3 |
+
o igual a 200 mg/dl
|
human_readable/txt/diarrhea_pacificislands
ADDED
|
@@ -0,0 +1,2 @@
|
|
|
|
|
|
|
|
|
|
| 1 |
+
3 or more loose or
|
| 2 |
+
watery stools in 24 hrs
|
human_readable/txt/ebola_spain
ADDED
|
@@ -0,0 +1,9 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Criterio clínico: Fiebre* (≥ 37,7 º C) con al menos otro síntoma compatible con la clínica de la enfermedad
|
| 2 |
+
(cefalea intensa, vómitos, diarrea, dolor abdominal, dolor muscular o manifestación hemorrágica no
|
| 3 |
+
explicada)
|
| 4 |
+
* Para valorar la fiebre, se deberá tener en cuenta si está tomando antitérmicos, está en situación de
|
| 5 |
+
inmunodepresión o cualquier otra situación que pueda afectar a la temperatura corporal, como son
|
| 6 |
+
los niños, ancianos, etc. En los lactantes, especialmente en los menores de 3 meses, la fiebre puede no
|
| 7 |
+
ser evidente y se deben valorar como criterio clínico los síntomas y signos de afectación sistémica.
|
| 8 |
+
El criterio clínico en contactos en seguimiento por haber estado expuestos a un caso de EVE será fiebre o
|
| 9 |
+
un cuadro clínico compatible con la enfermedad.
|
human_readable/txt/ebolaandmarburgvirus_who
ADDED
|
@@ -0,0 +1,9 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Suspected case:2
|
| 2 |
+
• any person, alive or dead, suffering or having suffered from sudden onset of high fever, and had
|
| 3 |
+
contact with:
|
| 4 |
+
o a suspected, probable, or confirmed Ebola case, or a dead or sick animal; OR
|
| 5 |
+
• any person with sudden onset of high fever, AND at least three of the following symptoms:
|
| 6 |
+
headache, lethargy, anorexia/loss of appetite, aching muscles or joints, stomach pain, difficulty
|
| 7 |
+
swallowing, vomiting, difficulty breathing, diarrhoea, hiccups; OR
|
| 8 |
+
• any person with inexplicable bleeding; OR
|
| 9 |
+
• any sudden, inexplicable death.
|
human_readable/txt/equineencephalitis_guatemala
ADDED
|
@@ -0,0 +1,9 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Definiciones de caso
|
| 2 |
+
En Población humana
|
| 3 |
+
• Caso sospechoso de encefalitis equina: Toda persona que presente fiebre de inicio
|
| 4 |
+
repentino, asociada a uno o más de los siguientes signos neurológicos: cefalea,
|
| 5 |
+
desorientación, temblores, convulsiones, parestesias, o algún tipo de parálisis,
|
| 6 |
+
somnolencia, alteración del estado de conciencia, estupor, rigidez de nuca y que hayan
|
| 7 |
+
visitado regiones con presencia de équidos (caballos, asnos y mulas) o bien, haber sufrido
|
| 8 |
+
picaduras de mosquitos en áreas con muerte de estos équidos sospechosos de padecer
|
| 9 |
+
encefalitis equina.
|
human_readable/txt/extremetemperaturescold_argentina
ADDED
|
@@ -0,0 +1,9 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
FRÍO: X31 (Exposición al frío natural excesivo)
|
| 2 |
+
Efectos en salud asociados al frío extremo: Toda persona con antecedentes de
|
| 3 |
+
exposición a frío extremo en circunstancia de Alerta Temprana por Temperatura
|
| 4 |
+
Extrema (frío) del Servicio Meteorológico Nacional, y sintomatología clínica
|
| 5 |
+
atribuible. Temperatura corporal igual o menor a 36 ºC y 2 o más de los siguientes
|
| 6 |
+
síntomas, a saber:
|
| 7 |
+
Signos y síntomas atribuibles: escalofríos, alteración del estado de conciencia, pulso
|
| 8 |
+
débil, bradipnea, daño tisular local causado por el enfriamiento. Piel fría y roja en
|
| 9 |
+
bebés.
|
human_readable/txt/extremetemperaturesheat_argentina
ADDED
|
@@ -0,0 +1,10 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
CALOR: X30 (Exposición al calor natural excesivo), T67 (Efectos del calor y la luz)
|
| 2 |
+
Efectos en salud asociados al calor extremo: Toda persona con antecedentes de
|
| 3 |
+
exposición a calor extremo en circunstancia de Alerta Temprana por Temperatura
|
| 4 |
+
Extrema (calor) del Servicio Meteorológico Nacional, y sintomatología clínica
|
| 5 |
+
atribuible - Temperatura corporal mayor o igual a 39 ºC y 2 o más de los siguientes
|
| 6 |
+
síntomas, a saber:
|
| 7 |
+
Signos y síntomas atribuibles: piel caliente, sudoración abundante en un primer
|
| 8 |
+
momento o escasa, náuseas y/o vómitos, hipotensión, taquicardia y taquipnea,
|
| 9 |
+
alteración del estado de conciencia, convulsiones, desmayo. En bebés: sudoración
|
| 10 |
+
abundante, piel irritada por sudor.
|
human_readable/txt/humannipahvirus_bangladesh
ADDED
|
@@ -0,0 +1,19 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Nipah like illness (Screening case definition) criteria:
|
| 2 |
+
|
| 3 |
+
Fever (axillary temperature >38.5°C) or history of raised temperature prior to hospitalization AND any sign/symptom of brain pathology
|
| 4 |
+
|
| 5 |
+
OR
|
| 6 |
+
|
| 7 |
+
Fever (axillary temperature >38.5°C) or history of raised temperature prior to hospitalization AND any sign/symptom of lung pathology
|
| 8 |
+
|
| 9 |
+
Suspected Nipah encephalitis criteria:
|
| 10 |
+
Fever or history of fever (axillary temperature >38.5°C) AND evidence of acute brain pathology (e.g., altered mental status, new-onset seizures, or new neurological deficit either diffuse or localized to the brain)
|
| 11 |
+
|
| 12 |
+
Suspected Nipah pneumonitis criteria:
|
| 13 |
+
Onset of illness within the last seven days AND fever or history of fever (axillary temperature >38.5°C) AND severe shortness of breath (i.e., dyspnea that prevents the patient from walking unassisted for not more than ten steps) AND chest radiograph consistent with diffuse acute respiratory distress syndrome
|
| 14 |
+
|
| 15 |
+
Probable Nipah infection criteria:
|
| 16 |
+
History of Nipah encephalitis or pneumonitis AND established epidemiological link with at least one confirmed Nipah case but the absence of laboratory confirmation due to the patient's death
|
| 17 |
+
|
| 18 |
+
Confirmed Nipah infection criteria:
|
| 19 |
+
Laboratory confirmation of the infection; either by identification of anti-Nipah IgM via ELISA (Enzyme-linked immunosorbent assay) OR through identification of viral particles by qRT-PCR (quantitative reverse transcription polymerase chain reaction) with or without a history of Nipah encephalitis/pneumonitis
|
human_readable/txt/influenzalikeillness_africa_africacdc
ADDED
|
@@ -0,0 +1,7 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Influenza-Like Illness (ILI) An acute respiratory infection with:
|
| 2 |
+
•
|
| 3 |
+
measured fever of ≥ 38 °C
|
| 4 |
+
•
|
| 5 |
+
and cough
|
| 6 |
+
•
|
| 7 |
+
with onset within the last 10 days
|
human_readable/txt/influenzalikeillness_brazil
ADDED
|
@@ -0,0 +1,9 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
2.1 DeFInIção De caso De sínDrome GrIpal ( sG):
|
| 2 |
+
Indivíduo que apresente febre de início súbito, mesmo que referida,
|
| 3 |
+
acompanhada de tosse ou dor de garganta e pelo menos um dos seguin-
|
| 4 |
+
tes sintomas: cefaleia, mialgia ou artralgia, na ausência de outro diagnós-
|
| 5 |
+
tico específico.
|
| 6 |
+
Em crianças menores de 2 anos de idade, considera-se também como
|
| 7 |
+
caso de síndrome gripal: febre de início súbito (mesmo que referida) e
|
| 8 |
+
sintomas respiratórios (tosse, coriza e obstrução nasal), na ausência de
|
| 9 |
+
outro diagnóstico específico.
|
human_readable/txt/intussusception_vietnam
ADDED
|
@@ -0,0 +1,12 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Level 1 of diagnostic certainty
|
| 2 |
+
Surgical criteria:
|
| 3 |
+
The demonstration of invagination of the intestine at surgery;
|
| 4 |
+
and/or
|
| 5 |
+
Radiological criteria:
|
| 6 |
+
The demonstration of invagination of the intestine by either air or liquid contrast enema;
|
| 7 |
+
or
|
| 8 |
+
The demonstration of an intra-abdominal mass by abdominal ultrasound with specific characteristic featuresb that is proven to be reduced by
|
| 9 |
+
hydrostatic enema on post-reduction ultrasound;
|
| 10 |
+
and/or
|
| 11 |
+
Autopsy criteria:
|
| 12 |
+
The demonstration of invagination of the intestine.
|
human_readable/txt/legionnairesdisease_uk
ADDED
|
@@ -0,0 +1,5 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
A case with clinical or radiological diagnosis of pneumonia but no
|
| 2 |
+
microbiological evidence for confirmation of Legionella infection (above) is
|
| 3 |
+
considered a probable case where the location and onset date(s) meet the
|
| 4 |
+
outbreak-specific case definition for the exposure category (described in the
|
| 5 |
+
section below).
|
human_readable/txt/leptospirosis_germany
ADDED
|
@@ -0,0 +1,12 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Klinisches Bild
|
| 2 |
+
Klinisches Bild einer akuten Leptospirose, definiert als mindestens eines der neun folgenden Kriterien:
|
| 3 |
+
- ►allgemeine Krankheitszeichen,
|
| 4 |
+
- Dyspnoe (Atemstörung),
|
| 5 |
+
- ►Fieber,
|
| 6 |
+
- Hämorrhagien (z.B. Lungenblutungen, subkonjunktivale Blutungen),
|
| 7 |
+
- Husten,
|
| 8 |
+
- Ikterus (Gelbsucht),
|
| 9 |
+
- Meningitis oder Meningoenzephalitis,
|
| 10 |
+
- Myokarditis (Herzmuskelentzündung),
|
| 11 |
+
- ►Nierenfunktionsstörung
|
| 12 |
+
ODER ►krankheitsbedingter Tod.
|
human_readable/txt/lujo_southafrica
ADDED
|
@@ -0,0 +1,22 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
A person with acute onset of fever
|
| 2 |
+
>38.5°C, and at least three of the
|
| 3 |
+
following signs and symptoms:
|
| 4 |
+
severe headache, myalgia,
|
| 5 |
+
diarrhea,
|
| 6 |
+
pharyngitis, abdominal pain,
|
| 7 |
+
retrosternal chest pain,
|
| 8 |
+
respiratory distress,
|
| 9 |
+
moderate thrombocytopenia,
|
| 10 |
+
increased AST and
|
| 11 |
+
leukocytosis,
|
| 12 |
+
proteinuria,
|
| 13 |
+
neurological signs or
|
| 14 |
+
sudden inexplicable death
|
| 15 |
+
AND a likely epidemiological exposure
|
| 16 |
+
including any of
|
| 17 |
+
contact with a suspected,
|
| 18 |
+
probable or confirmed Lujo case,
|
| 19 |
+
or
|
| 20 |
+
contact with a dead or sick
|
| 21 |
+
animal especially rodents within
|
| 22 |
+
the past 21 days.
|
human_readable/txt/malaria_nigeria
ADDED
|
@@ -0,0 +1,3 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Unconfirmed severe malaria
|
| 2 |
+
Any patient hospitalized with severe febrile disease with accompanying vital organ
|
| 3 |
+
dysfunction diagnosed clinically.
|
human_readable/txt/measles_china
ADDED
|
@@ -0,0 +1,2 @@
|
|
|
|
|
|
|
|
|
|
| 1 |
+
1.疑似病例
|
| 2 |
+
发热,出疹(全身性斑丘疹)并伴有咳嗽,卡他性⿐炎或结膜炎症状之⼀者,或任何经过训练的卫⽣⼈员诊断为麻疹的病例均为疑似麻疹病例.
|
human_readable/txt/measles_ethiopia
ADDED
|
@@ -0,0 +1,6 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
National guidelines for measles surveillance are based on
|
| 2 |
+
the WHO/-AFRO Measles and Rubella Surveillance guide-
|
| 3 |
+
line, and define a suspected measles case as any person
|
| 4 |
+
with a generalized maculopapular rash and fever plus one or
|
| 5 |
+
more of the following: 1) cough, 2) coryza), or 3) conjunc-
|
| 6 |
+
tivitis OR any person in whom a clinician suspects measles.
|
human_readable/txt/measles_india
ADDED
|
@@ -0,0 +1,5 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
11. Measles • A suspected measles case is any person with fever and maculopapular rash (non-vesicular)
|
| 2 |
+
OR
|
| 3 |
+
• any person in whom a health worker or clinician suspects measles infection
|
| 4 |
+
**A probable rabid animal is a suspected rabid animal (as defined above) with additional histor y of a
|
| 5 |
+
bite by another suspected / probable /confirmed rabid animal and/or is a suspected rabid animal that is
|
human_readable/txt/meningococcalmeningitis_mozambique
ADDED
|
@@ -0,0 +1,6 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Caso suspeito: Uma pessoa com
|
| 2 |
+
manifestação súbita de febre
|
| 3 |
+
(>38,5º C no recto ou 38,0º C nas
|
| 4 |
+
axilas), e pescoço rígido, con-
|
| 5 |
+
sciência alterada ou quaisquer
|
| 6 |
+
outros sinais meníngeos.
|
human_readable/txt/middleeastrespiratorysyndrome_saudiarabia
ADDED
|
@@ -0,0 +1,22 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Children
|
| 2 |
+
III. Acute febrile illness (T ≥380 C)
|
| 3 |
+
Within 14 days before symptom
|
| 4 |
+
and adults
|
| 5 |
+
with/without respiratory symptoms
|
| 6 |
+
onset:
|
| 7 |
+
OR
|
| 8 |
+
1. Exposure 4 to a confirmed case
|
| 9 |
+
of MERS-CoV infection OR
|
| 10 |
+
IV. Gastrointestinal symptoms
|
| 11 |
+
2. Visit to a healthcare facility
|
| 12 |
+
(diarrhea or vomiting), AND
|
| 13 |
+
where MERS-CoV patients(s)
|
| 14 |
+
leukopenia (WBC≤3.5x109 /L) or
|
| 15 |
+
has recently (within 2 weeks)
|
| 16 |
+
thrombocytopenia (platelets <
|
| 17 |
+
been identified/treated OR
|
| 18 |
+
150x109/L)
|
| 19 |
+
3. Contact with dromedary
|
| 20 |
+
camels5 or consumption of
|
| 21 |
+
camel products (e.g. raw meat,
|
| 22 |
+
unpasteurized milk, urine)
|
human_readable/txt/mpox_france
ADDED
|
@@ -0,0 +1,6 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Patient suspect de mpox = signes cliniques évocateurs uniquement
|
| 2 |
+
Un patient suspect d’infection par le virus Monkeypox est une personne présentant
|
| 3 |
+
- Une éruption cutanée ou une ou des ulcérations de la muqueuse génitale, anale ou buccale,
|
| 4 |
+
évocatrice de mpox
|
| 5 |
+
- Isolée, ou précédée ou accompagnée d’une fièvre ressentie ou mesurée (>38°C),
|
| 6 |
+
d’adénopathies ou d’une odynophagie.
|
human_readable/txt/mumps_ireland
ADDED
|
@@ -0,0 +1,4 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Clinical criteria
|
| 2 |
+
Any person with fever AND sudden onset of unilateral or bilateral tender swelling of the parotid or other salivary
|
| 3 |
+
glands without other apparent cause. Mumps may also present as aseptic meningitis, encephalitis, hearing loss,
|
| 4 |
+
orchitis, oophoritis, parotitis or other salivary gland swelling, mastitis or pancreatitis.
|
human_readable/txt/plague_peru
ADDED
|
@@ -0,0 +1,7 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Caso Sospechoso de Peste:
|
| 2 |
+
Paciente con presentación clínica compatible, y con antecedentes
|
| 3 |
+
epidemiológicos consistentes de:
|
| 4 |
+
• Exposición a humanos o animales infectados, y/o
|
| 5 |
+
• Evidencia de picaduras de pulgas, y/o
|
| 6 |
+
• Residencia o viaje a un área endémica conocida, dentro de los 10 días
|
| 7 |
+
previos.
|
human_readable/txt/smallpox_costarica
ADDED
|
@@ -0,0 +1,18 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Persona de cualquier edad que se presenta con un exantema agudo inexplicable y que
|
| 2 |
+
presentó uno o más de los siguientes signos o síntomas, con fecha de inicio posterior al 15
|
| 3 |
+
de marzo de 2022:
|
| 4 |
+
- Cefalea
|
| 5 |
+
- Inicio súbito fiebre (>38,5°C)
|
| 6 |
+
- Mialgia
|
| 7 |
+
- Dolor de espalda
|
| 8 |
+
- Astenia
|
| 9 |
+
- Linfadenopatía
|
| 10 |
+
Y
|
| 11 |
+
para los cuales se ha descartado, las siguientes y otras causas de exantema agudo que se
|
| 12 |
+
mencionan a continuación: varicela, herpes zóster, sarampión, rubéola, zika, dengue,
|
| 13 |
+
chikungunya, herpes simple, infecciones bacterianas de la piel, infección gonocócica
|
| 14 |
+
diseminada, sífilis primaria o secundaria, chancroide, linfogranuloma venéreo, granuloma
|
| 15 |
+
inguinal, molusco contagioso, reacción alérgica (por ejemplo, a las plantas); y cualquier otra
|
| 16 |
+
causa común, localmente relevante de erupción vesicular o papular.
|
| 17 |
+
No es necesario tener resultados negativos de todas las enfermedades exantemáticas para
|
| 18 |
+
determinar un caso como sospechoso.
|
human_readable/txt/syphiliscongenitalandneonatal_greece
ADDED
|
@@ -0,0 +1,22 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Κλινικά Κριτήρια
|
| 2 |
+
Κάθε άτομο με μια τουλάχιστον από τις ακόλουθες κλινικές μορφές:
|
| 3 |
+
Γριπώδης Συνδρομή (I.L.I.)
|
| 4 |
+
– Αιφνίδια έναρξη συμπτωμάτων
|
| 5 |
+
ΚΑΙ τουλάχιστον ένα από τα τέσσερα ακόλουθα συστηματικά συμπτώματα:
|
| 6 |
+
– Πυρετός
|
| 7 |
+
– Κακουχία
|
| 8 |
+
– Κεφαλαλγία
|
| 9 |
+
– Μυαλγία
|
| 10 |
+
ΚΑΙ τουλάχιστον ένα από τα τρία ακόλουθα συμπτώματα από το αναπνευστικό:
|
| 11 |
+
– Βήχας
|
| 12 |
+
– Φαρυγγαλγία
|
| 13 |
+
– Αναπνευστική δυσχέρεια
|
| 14 |
+
Οξεία Λοίμωξη του αναπνευστικού (A.R.I)
|
| 15 |
+
– Αιφνίδια έναρξη συμπτωμάτων
|
| 16 |
+
ΚΑΙ τουλάχιστον ένα από τα ακόλουθα τέσσερα συμπτώματα από το αναπνευστικό:
|
| 17 |
+
– Βήχας
|
| 18 |
+
– Φαρυγγαλγία
|
| 19 |
+
– Αναπνευστική δυσχέρεια
|
| 20 |
+
– Καταρροή
|
| 21 |
+
ΚΑΙ
|
| 22 |
+
Εκτίμηση κλινικού ιατρού ότι πρόκειται για λοίμωξη του αναπνευστικού.
|
human_readable/txt/tuberculosis_europe_ecdc
ADDED
|
@@ -0,0 +1,8 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Clinical Criteria
|
| 2 |
+
Any person with the following two:
|
| 3 |
+
— Signs, symptoms and/or radiological findings consistent with active tuberculosis in any site
|
| 4 |
+
AND
|
| 5 |
+
— A clinician's decision to treat the person with a full course of anti-tuberculosis therapy
|
| 6 |
+
OR
|
| 7 |
+
A case discovered post-mortem with pathological findings consistent with active tuberculosis that would have indicated
|
| 8 |
+
anti-tuberculosis antibiotic treatment had the patient been diagnosed before dying
|
human_readable/txt/viralhepatitis_turkey
ADDED
|
@@ -0,0 +1,8 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
|
| 2 |
+
Aşağıdaki iki klinik kriterin görülmesidir.
|
| 3 |
+
1. Bir kişide ani başlayan karın ağrısı, iştahsızlık, halsizlik, bulantı, kusma
|
| 4 |
+
2. Aşağıdaki klinik kriterlerden en az birisinin olması
|
| 5 |
+
• Ateş
|
| 6 |
+
• Sarılık
|
| 7 |
+
• Serum aminotransferaz (ALT ve AST), idrarda ürobilinojen düzeyinin yükselmesi
|
| 8 |
+
(NOT: Çoğunlukla asemptomatik ve/veya anikterik seyredebileceği hatırlanmalıdır.)Hepatit A Epidemiyolojik Kriter
|
human_readable/txt/wheezeorapneaorcyanosis_pakistan
ADDED
|
@@ -0,0 +1 @@
|
|
|
|
|
|
|
| 1 |
+
wheeze or apnea or cyanosis
|
human_readable/txt/zika_paho
ADDED
|
@@ -0,0 +1,8 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Suspected case of Zika virus disease
|
| 2 |
+
Patient with rash* with two or more of the following signs or symptoms:
|
| 3 |
+
• fever, usually <38.5 ° C
|
| 4 |
+
• conjunctivitis (non-purulent/hyperemic)
|
| 5 |
+
• arthralgia
|
| 6 |
+
• myalgia
|
| 7 |
+
• peri-articular edema
|
| 8 |
+
*usually pruritic and maculopapular
|
machine_readable/.DS_Store
ADDED
|
Binary file (6.15 kB). View file
|
|
|
machine_readable/json/chlamydia_newzealand.json
ADDED
|
@@ -0,0 +1,59 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"title": "Open Syndrome Chlamydia",
|
| 3 |
+
"description": "Laboratory detection of Chlamydia trachomatis in a clinical specimen.",
|
| 4 |
+
"published_in": "https://opensyndrome.org",
|
| 5 |
+
"published_at": "2025-02-25T12:05:42Z",
|
| 6 |
+
"published_by": [
|
| 7 |
+
"Open Syndrome Initiative"
|
| 8 |
+
],
|
| 9 |
+
"open_syndrome_version": "1.0.0",
|
| 10 |
+
"status": "draft",
|
| 11 |
+
"organization": "Institute of Environmental Science and Research",
|
| 12 |
+
"location": "New Zealand",
|
| 13 |
+
"language": "English",
|
| 14 |
+
"version": "1.0.0",
|
| 15 |
+
"category": "confirmed",
|
| 16 |
+
"scope": "broad",
|
| 17 |
+
"inclusion_criteria": [
|
| 18 |
+
{
|
| 19 |
+
"type": "diagnosis",
|
| 20 |
+
"name": "uncomplicated infection of the lower anogenital tract",
|
| 21 |
+
"description": "Anogenital includes urogenital and anorectal infection."
|
| 22 |
+
},
|
| 23 |
+
{
|
| 24 |
+
"logical_operator": "OR",
|
| 25 |
+
"type": "criterion",
|
| 26 |
+
"name": "PID (pelvic inflammatory disease) or epididymitis",
|
| 27 |
+
"values": [
|
| 28 |
+
{
|
| 29 |
+
"type": "diagnosis",
|
| 30 |
+
"name": "pelvic inflammatory disease",
|
| 31 |
+
"description": "PID"
|
| 32 |
+
},
|
| 33 |
+
{
|
| 34 |
+
"type": "diagnosis",
|
| 35 |
+
"name": "epididymitis"
|
| 36 |
+
}
|
| 37 |
+
]
|
| 38 |
+
},
|
| 39 |
+
{
|
| 40 |
+
"name": "infection of another site (eg, eye or pharynx)",
|
| 41 |
+
"description": "eg, eye or pharynx",
|
| 42 |
+
"type": "diagnosis"
|
| 43 |
+
}
|
| 44 |
+
],
|
| 45 |
+
"references": [
|
| 46 |
+
{
|
| 47 |
+
"url": "https://www.esr.cri.nz/media/0nadzkgc/sticasedefinitions.pdf"
|
| 48 |
+
}
|
| 49 |
+
],
|
| 50 |
+
"human_readable_definition": "",
|
| 51 |
+
"target_public_health_threats": [
|
| 52 |
+
"Chlamydia"
|
| 53 |
+
],
|
| 54 |
+
"keywords": [
|
| 55 |
+
"Chlamydia",
|
| 56 |
+
"Oceania"
|
| 57 |
+
],
|
| 58 |
+
"definition_type": "case_definition"
|
| 59 |
+
}
|
machine_readable/json/ebolaandmarburgvirus_who.json
ADDED
|
@@ -0,0 +1,133 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"title": "Open Syndrome Ebola Marburg Virus Cases",
|
| 3 |
+
"description": "",
|
| 4 |
+
"scope": "specific",
|
| 5 |
+
"category": "suspected",
|
| 6 |
+
"version": "1.0.0",
|
| 7 |
+
"published_in": "https://opensyndrome.org",
|
| 8 |
+
"published_at": "2025-02-08T18:26:37Z",
|
| 9 |
+
"published_by": [
|
| 10 |
+
"Open Syndrome Initiative"
|
| 11 |
+
],
|
| 12 |
+
"open_syndrome_version": "1.0.0",
|
| 13 |
+
"location": "Global",
|
| 14 |
+
"language": "English",
|
| 15 |
+
"organization": "Open Syndrome Initiative",
|
| 16 |
+
"inclusion_criteria": [
|
| 17 |
+
{
|
| 18 |
+
"type": "criterion",
|
| 19 |
+
"logical_operator": "OR",
|
| 20 |
+
"values": [
|
| 21 |
+
{
|
| 22 |
+
"type": "criterion",
|
| 23 |
+
"logical_operator": "AND",
|
| 24 |
+
"name": "High fever and epidemiological history",
|
| 25 |
+
"values": [
|
| 26 |
+
{
|
| 27 |
+
"type": "symptom",
|
| 28 |
+
"name": "Sudden onset of high fever"
|
| 29 |
+
},
|
| 30 |
+
{
|
| 31 |
+
"type": "criterion",
|
| 32 |
+
"logical_operator": "OR",
|
| 33 |
+
"values": [
|
| 34 |
+
{
|
| 35 |
+
"type": "epidemiological_history",
|
| 36 |
+
"name": "Contact with a suspected, probable, or confirmed Ebola case"
|
| 37 |
+
},
|
| 38 |
+
{
|
| 39 |
+
"type": "epidemiological_history",
|
| 40 |
+
"name": "Contact with a dead or sick animal"
|
| 41 |
+
}
|
| 42 |
+
]
|
| 43 |
+
}
|
| 44 |
+
]
|
| 45 |
+
},
|
| 46 |
+
{
|
| 47 |
+
"type": "criterion",
|
| 48 |
+
"logical_operator": "AND",
|
| 49 |
+
"name": "High fever and at least 3 of the following symptoms",
|
| 50 |
+
"values": [
|
| 51 |
+
{
|
| 52 |
+
"type": "symptom",
|
| 53 |
+
"name": "Sudden onset of high fever"
|
| 54 |
+
},
|
| 55 |
+
{
|
| 56 |
+
"type": "criterion",
|
| 57 |
+
"logical_operator": "AT_LEAST",
|
| 58 |
+
"logical_operator_arguments": [
|
| 59 |
+
3
|
| 60 |
+
],
|
| 61 |
+
"values": [
|
| 62 |
+
{
|
| 63 |
+
"type": "symptom",
|
| 64 |
+
"name": "Headache"
|
| 65 |
+
},
|
| 66 |
+
{
|
| 67 |
+
"type": "symptom",
|
| 68 |
+
"name": "Lethargy"
|
| 69 |
+
},
|
| 70 |
+
{
|
| 71 |
+
"type": "symptom",
|
| 72 |
+
"name": "Anorexia/loss of appetite"
|
| 73 |
+
},
|
| 74 |
+
{
|
| 75 |
+
"type": "symptom",
|
| 76 |
+
"name": "Aching muscles or joints"
|
| 77 |
+
},
|
| 78 |
+
{
|
| 79 |
+
"type": "symptom",
|
| 80 |
+
"name": "Stomach pain"
|
| 81 |
+
},
|
| 82 |
+
{
|
| 83 |
+
"type": "symptom",
|
| 84 |
+
"name": "Difficulty swallowing"
|
| 85 |
+
},
|
| 86 |
+
{
|
| 87 |
+
"type": "symptom",
|
| 88 |
+
"name": "Vomiting"
|
| 89 |
+
},
|
| 90 |
+
{
|
| 91 |
+
"type": "symptom",
|
| 92 |
+
"name": "Difficulty breathing"
|
| 93 |
+
},
|
| 94 |
+
{
|
| 95 |
+
"type": "symptom",
|
| 96 |
+
"name": "Diarrhea"
|
| 97 |
+
},
|
| 98 |
+
{
|
| 99 |
+
"type": "symptom",
|
| 100 |
+
"name": "Hiccups"
|
| 101 |
+
}
|
| 102 |
+
]
|
| 103 |
+
}
|
| 104 |
+
]
|
| 105 |
+
},
|
| 106 |
+
{
|
| 107 |
+
"type": "symptom",
|
| 108 |
+
"name": "Inexplicable bleeding"
|
| 109 |
+
},
|
| 110 |
+
{
|
| 111 |
+
"type": "professional_judgment",
|
| 112 |
+
"name": "Sudden, inexplicable death"
|
| 113 |
+
}
|
| 114 |
+
]
|
| 115 |
+
}
|
| 116 |
+
],
|
| 117 |
+
"references": [
|
| 118 |
+
{
|
| 119 |
+
"url": "https://www.who.int/emergencies/outbreak-toolkit/disease-outbreak-toolboxes/ebola-and-marburg-virus-outbreak-toolbox"
|
| 120 |
+
}
|
| 121 |
+
],
|
| 122 |
+
"status": "draft",
|
| 123 |
+
"human_readable_definition": "any person, alive or dead, suffering or having suffered from sudden onset of high fever, and had\ncontact with:\no a suspected, probable, or confirmed Ebola case, or a dead or sick animal; OR\n• any person with sudden onset of high fever, AND at least three of the following symptoms:\nheadache, lethargy, anorexia/loss of appetite, aching muscles or joints, stomach pain, difficulty\nswallowing, vomiting, difficulty breathing, diarrhoea, hiccups; OR\n• any person with inexplicable bleeding; OR\n• any sudden, inexplicable death.",
|
| 124 |
+
"target_public_health_threats": [
|
| 125 |
+
"Ebola and Marburg virus"
|
| 126 |
+
],
|
| 127 |
+
"keywords": [
|
| 128 |
+
"Ebola",
|
| 129 |
+
"Marburg virus",
|
| 130 |
+
"WHO"
|
| 131 |
+
],
|
| 132 |
+
"definition_type": "case_definition"
|
| 133 |
+
}
|
machine_readable/json/lujo_southafrica.json
ADDED
|
@@ -0,0 +1,124 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"title": "Open Syndrome Lujo Hemorrhagic Fever",
|
| 3 |
+
"description": "Case definition for suspected Lujo viral hemorrhagic fever",
|
| 4 |
+
"scope": "specific",
|
| 5 |
+
"category": "suspected",
|
| 6 |
+
"version": "1.0.0",
|
| 7 |
+
"open_syndrome_version": "1.0.0",
|
| 8 |
+
"published_in": "https://opensyndrome.org",
|
| 9 |
+
"published_at": "2025-01-29T12:00:00Z",
|
| 10 |
+
"published_by": [
|
| 11 |
+
"Open Syndrome Initiative"
|
| 12 |
+
],
|
| 13 |
+
"location": "South Africa",
|
| 14 |
+
"language": "English",
|
| 15 |
+
"organization": "National Institute for Communicable Diseases (NICD)",
|
| 16 |
+
"inclusion_criteria": [
|
| 17 |
+
{
|
| 18 |
+
"type": "criterion",
|
| 19 |
+
"logical_operator": "AND",
|
| 20 |
+
"values": [
|
| 21 |
+
{
|
| 22 |
+
"type": "symptom",
|
| 23 |
+
"name": "fever",
|
| 24 |
+
"description": ">38.5°C"
|
| 25 |
+
},
|
| 26 |
+
{
|
| 27 |
+
"type": "criterion",
|
| 28 |
+
"logical_operator": "AT_LEAST",
|
| 29 |
+
"logical_operator_arguments": [
|
| 30 |
+
3
|
| 31 |
+
],
|
| 32 |
+
"values": [
|
| 33 |
+
{
|
| 34 |
+
"type": "symptom",
|
| 35 |
+
"name": "severe headache"
|
| 36 |
+
},
|
| 37 |
+
{
|
| 38 |
+
"type": "symptom",
|
| 39 |
+
"name": "myalgia"
|
| 40 |
+
},
|
| 41 |
+
{
|
| 42 |
+
"type": "symptom",
|
| 43 |
+
"name": "diarrhea"
|
| 44 |
+
},
|
| 45 |
+
{
|
| 46 |
+
"type": "symptom",
|
| 47 |
+
"name": "pharyngitis"
|
| 48 |
+
},
|
| 49 |
+
{
|
| 50 |
+
"type": "symptom",
|
| 51 |
+
"name": "abdominal pain"
|
| 52 |
+
},
|
| 53 |
+
{
|
| 54 |
+
"type": "symptom",
|
| 55 |
+
"name": "retrosternal chest pain"
|
| 56 |
+
},
|
| 57 |
+
{
|
| 58 |
+
"type": "symptom",
|
| 59 |
+
"name": "respiratory distress"
|
| 60 |
+
},
|
| 61 |
+
{
|
| 62 |
+
"type": "symptom",
|
| 63 |
+
"name": "moderate thrombocytopenia"
|
| 64 |
+
},
|
| 65 |
+
{
|
| 66 |
+
"type": "symptom",
|
| 67 |
+
"name": "increased AST"
|
| 68 |
+
},
|
| 69 |
+
{
|
| 70 |
+
"type": "symptom",
|
| 71 |
+
"name": "leukocytosis"
|
| 72 |
+
},
|
| 73 |
+
{
|
| 74 |
+
"type": "symptom",
|
| 75 |
+
"name": "proteinuria"
|
| 76 |
+
},
|
| 77 |
+
{
|
| 78 |
+
"type": "symptom",
|
| 79 |
+
"name": "neurological signs"
|
| 80 |
+
},
|
| 81 |
+
{
|
| 82 |
+
"type": "symptom",
|
| 83 |
+
"name": "sudden inexplicable death"
|
| 84 |
+
}
|
| 85 |
+
]
|
| 86 |
+
},
|
| 87 |
+
{
|
| 88 |
+
"type": "criterion",
|
| 89 |
+
"logical_operator": "AT_LEAST",
|
| 90 |
+
"logical_operator_arguments": [
|
| 91 |
+
1
|
| 92 |
+
],
|
| 93 |
+
"values": [
|
| 94 |
+
{
|
| 95 |
+
"type": "epidemiological_history",
|
| 96 |
+
"name": "contact with Lujo case",
|
| 97 |
+
"description": "Contact with a suspected, probable or confirmed Lujo case within past 21 days"
|
| 98 |
+
},
|
| 99 |
+
{
|
| 100 |
+
"type": "epidemiological_history",
|
| 101 |
+
"name": "contact with animal",
|
| 102 |
+
"description": "Contact with a dead or sick animal especially rodents within past 21 days"
|
| 103 |
+
}
|
| 104 |
+
]
|
| 105 |
+
}
|
| 106 |
+
]
|
| 107 |
+
}
|
| 108 |
+
],
|
| 109 |
+
"references": [
|
| 110 |
+
{
|
| 111 |
+
"url": "https://www.nicd.ac.za/wp-content/uploads/2021/08/VIRAL-HAEMORRHAGIC-FEVER-DISEASES_Lujo-case-definition.pdf"
|
| 112 |
+
}
|
| 113 |
+
],
|
| 114 |
+
"status": "draft",
|
| 115 |
+
"human_readable_definition": "A person with acute onset of fever\n>38.5°C, and at least three of the\nfollowing signs and symptoms:\n\uF0B7 severe headache, myalgia,\n\uF0B7 diarrhea,\n\uF0B7 pharyngitis, abdominal pain,\nretrosternal chest pain,\nrespiratory distress,\n\uF0B7 moderate thrombocytopenia,\n\uF0B7 increased AST and\n\uF0B7 leukocytosis,\n\uF0B7 proteinuria,\n\uF0B7 neurological signs or\n\uF0B7 sudden inexplicable death\nAND a likely epidemiological exposure\nincluding any of\n\uF0B7 contact with a suspected,\nprobable or confirmed Lujo case,\nor\n\uF0B7 contact with a dead or sick\nanimal especially rodents within\nthe past 21 days.",
|
| 116 |
+
"target_public_health_threats": [
|
| 117 |
+
"Lujo hemorrhagic fever"
|
| 118 |
+
],
|
| 119 |
+
"keywords": [
|
| 120 |
+
"Lujo hemorrhagic fever",
|
| 121 |
+
"Africa"
|
| 122 |
+
],
|
| 123 |
+
"definition_type": "case_definition"
|
| 124 |
+
}
|
machine_readable/json/measles_china.json
ADDED
|
@@ -0,0 +1,79 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{
|
| 2 |
+
"title": "Open Syndrome Measles",
|
| 3 |
+
"description": "",
|
| 4 |
+
"scope": "broad",
|
| 5 |
+
"category": "suspected",
|
| 6 |
+
"version": "1.0.0",
|
| 7 |
+
"open_syndrome_version": "1.0.0",
|
| 8 |
+
"published_in": "https://opensyndrome.org",
|
| 9 |
+
"published_at": "2025-02-27T17:48:51Z",
|
| 10 |
+
"published_by": [
|
| 11 |
+
"Open Syndrome Initiative"
|
| 12 |
+
],
|
| 13 |
+
"status": "draft",
|
| 14 |
+
"language": "English",
|
| 15 |
+
"organization": "China CDC",
|
| 16 |
+
"location": "China",
|
| 17 |
+
"inclusion_criteria": [
|
| 18 |
+
{
|
| 19 |
+
"type": "criterion",
|
| 20 |
+
"name": "Symptoms or professional diagnosis",
|
| 21 |
+
"logical_operator": "OR",
|
| 22 |
+
"values": [
|
| 23 |
+
{
|
| 24 |
+
"type": "criterion",
|
| 25 |
+
"logical_operator": "AND",
|
| 26 |
+
"values": [
|
| 27 |
+
{
|
| 28 |
+
"type": "symptom",
|
| 29 |
+
"name": "Fever"
|
| 30 |
+
},
|
| 31 |
+
{
|
| 32 |
+
"type": "symptom",
|
| 33 |
+
"name": "Rash (maculopapular rash)"
|
| 34 |
+
},
|
| 35 |
+
{
|
| 36 |
+
"type": "symptom",
|
| 37 |
+
"name": "Cough"
|
| 38 |
+
},
|
| 39 |
+
{
|
| 40 |
+
"type": "criterion",
|
| 41 |
+
"logical_operator": "AT_LEAST",
|
| 42 |
+
"logical_operator_arguments": [
|
| 43 |
+
1
|
| 44 |
+
],
|
| 45 |
+
"values": [
|
| 46 |
+
{
|
| 47 |
+
"type": "symptom",
|
| 48 |
+
"name": "Catarrhal fever"
|
| 49 |
+
},
|
| 50 |
+
{
|
| 51 |
+
"type": "symptom",
|
| 52 |
+
"name": "Conjunctivitis"
|
| 53 |
+
}
|
| 54 |
+
]
|
| 55 |
+
}
|
| 56 |
+
]
|
| 57 |
+
},
|
| 58 |
+
{
|
| 59 |
+
"type": "professional_judgment",
|
| 60 |
+
"name": "Measles diagnosed by any trained health worker"
|
| 61 |
+
}
|
| 62 |
+
]
|
| 63 |
+
}
|
| 64 |
+
],
|
| 65 |
+
"references": [
|
| 66 |
+
{
|
| 67 |
+
"url": "https://www.chinacdc.cn/jkyj/crb2/yl/mz/jswj_mz/202409/t20240909_299153.html"
|
| 68 |
+
}
|
| 69 |
+
],
|
| 70 |
+
"human_readable_definition": "未进行流行病学调查或完成调查前失访或死亡的病例,实验室检测结果为阴性或无实验室诊断结果的临床报告病例,且与实验室确诊病例没有流行病联系.",
|
| 71 |
+
"target_public_health_threats": [
|
| 72 |
+
"Measles"
|
| 73 |
+
],
|
| 74 |
+
"keywords": [
|
| 75 |
+
"Measles",
|
| 76 |
+
"Asia"
|
| 77 |
+
],
|
| 78 |
+
"definition_type": "case_definition"
|
| 79 |
+
}
|